E1	Condition:T1 Name:T2
E5	Condition:T5 Name:T6 Stability:T53
E6	Age:T10 Numeric-Filter:E10
E8	Eq-Comparison:T23 Operator:T7 Value:T20 Operator2:T43 Unit:T42
E9	Eq-Comparison:T24 Operator:T8 Value:T22 Unit:T59
E10	Eq-Comparison:T25 Operator:T12 Value:T14 Value2:T15 Temporal-Unit:T9
E11	Eq-Comparison:T26 Operator:T13 Value:T19 Value2:T38 Value3:T39 Value4:T18
E3	Study:T11 
E7	Modifier:T29 Modifies:T2
E12	Modifier:T30 Modifies:T2
E14	Observation:T32 Name:T33 Numeric-Filter:E15
E16	Modifier:T35 Modifies:T33
E15	Eq-Comparison:T34 Operator:T36 Value:T16 Value2:T17 Unit:T37
E17	Observation:T40 Name:T41 Numeric-Filter:E11
E18	Observation:T44 Name:T45 Numeric-Filter:E19
E19	Eq-Comparison:T47 Value:T21 Value2:T46
E20	Study:T48 
E22	Condition:T50 Name:T51
E23	Modifier:T52 Modifies:T51
E25	Condition:T55 Name:T56
E26	Observation:T57 Name:T58 Numeric-Filter:E9
E27	Modifier:T60 Modifies:T58
E28	Procedure:T61 Name:T62
E29	Study:T63 
T1	Condition 216 233	diabetes mellitus
T2	Condition-Name 216 233	diabetes mellitus
T3	Life-Stage-And-Gender 116 122	female
T4	Life-Stage-And-Gender 107 111	Male
T5	Condition 538 544	vision
T6	Condition-Name 538 544	vision
T7	Eq-Operator 404 405	≥
T8	Eq-Operator 599 600	≥
T9	Eq-Temporal-Unit 145 150	years
T10	Age 132 135	age
T12	Eq-Operator 139 141	to
T13	Eq-Operator 353 354	-
T14	Eq-Value 136 138	18
T15	Eq-Value 142 144	85
T16	Eq-Value 295 297	24
T17	Eq-Value 302 304	70
T18	Eq-Value 348 350	20
T19	Eq-Value 354 356	20
T20	Eq-Value 405 407	34
T21	Eq-Value 461 463	20
T22	Eq-Value 601 604	320
T23	Eq-Comparison 404 425	≥34 letters or better
T24	Eq-Comparison 599 607	≥ 320 µm
T25	Eq-Comparison 136 150	18 to 85 years
T26	Eq-Comparison 353 356	-20
T11	Study 171 180	screening
T29	Modifier 208 215	type II
T30	Modifier 198 204	type I
T32	Observation 243 261	ETDRS letter score
T33	Observation-Name 243 261	ETDRS letter score
T35	Modifier 275 278	eye
T34	Eq-Comparison 287 312	between 24 and 70 letters
T36	Eq-Operator 287 294	between
T37	Eq-Unit 305 312	letters
T38	Eq-Value 351 353	40
T39	Eq-Value 357 360	320
T40	Observation 326 333	Snellen
T41	Observation-Name 326 333	Snellen
T42	Eq-Unit 408 415	letters
T43	Eq-Operator 416 425	or better
T44	Observation 439 446	Snellen
T45	Observation-Name 439 446	Snellen
T46	Eq-Value 464 467	200
T47	Eq-Comparison 461 467	20/200
T48	Study 472 481	screening
T50	Condition 499 502	DME
T51	Condition-Name 499 502	DME
T52	Modifier 516 519	eye
T53	Stability 526 534	decrease
T55	Condition 552 569	foveal thickening
T56	Condition-Name 552 569	foveal thickening
T57	Observation 573 598	central macular thickness
T58	Observation-Name 573 598	central macular thickness
T59	Eq-Unit 605 607	µm
T60	Modifier 615 631	central subfield
T61	Procedure 648 654	SD-OCT
T62	Procedure-Name 648 654	SD-OCT
T63	Study 702 711	screening
A1	Life-Stage-And-Gender-Type T3 female
A2	Life-Stage-And-Gender-Type T4 male
A3	Eq-Operator-Value T7 GTEQ
A4	Eq-Operator-Value T8 GTEQ
A5	Eq-Temporal-Unit-Value T9 year
A6	Eq-Operator-Value T12 BETWEEN
A7	Eq-Operator-Value T13 BETWEEN
A9	Observation-Type-Value E14 clinical-score
A10	Eq-Operator-Value T36 BETWEEN
A11	Eq-Operator-Value T43 GTEQ
A13	Stability-Value T53 change
A14	Observation-Type-Value E26 measurement
R1	Equivalent-To Arg1:E17 Arg2:E14
R2	Caused-By Arg1:E5 Arg2:E25
R3	Found-By Arg1:E26 Arg2:E28
R4	Or Arg1:T4 Arg2:T3
R5	During Arg1:E6 Arg2:E3
R6	Or Arg1:E12 Arg2:E7
R7	During Arg1:E18 Arg2:E20
R8	And Arg1:E22 Arg2:T53
R9	During Arg1:E28 Arg2:E29
